MedTrace Logo

Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive Therapy

NCT06394466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 453

Last updated 2024-05-01

No results posted yet for this study

Summary

The assessment of ovarian reserve is well established based on the dosage of anti-Mullerian hormone (AMH). The clinical applicability of detecting thyroid autoantibodies levels has been discussed as a potential marker of low-grade inflammation. There are no studies about the detection of these autoantibodies in infertile women. Our objective is to evaluate the association between ovarian reserve and thyroid function and its autoimmunity in infertile women seeking for assisted reproductive treatment (ART).Evaluation ot thyroid function in the first trimester in also be evaluated in women submitted to ART.

Conditions

  • Ovarian Failure
  • Thyroid Diseases

Interventions

OTHER

Non Applicable

Non Applicable

Sponsors & Collaborators

  • Rio de Janeiro State University

    lead OTHER

Principal Investigators

  • Ana BW Tavares, pHD · Rio de Janeiro State University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06394466 on ClinicalTrials.gov